glp-1 receptor agonist agent Evolution of GLP‐1 Agonists for Diabetes Treatment Glucagon-like peptide-1 - Wikipedia
Description
Bezin, J., Gouverneur, A., Pnichon, M., Mathieu, C., Garrel, R., Hillaire-Buys, D., Pariente, A., & Faillie, J
Research has found that approximately 40% of the weight lost from taking semaglutide comes from lean mass, including muscle
doi:10.24870/cjb.2017-000107 34
Adding resistance training to the protocol shifts this ratio toward greater fat loss with better muscle preservation
Obesity is a clear risk factor for IIH, and GLP-1 receptor agonists have been some of the most effective treatments for obesity to date
(Basel)
